Cargando…

Serum antioxidant status and mortality from influenza and pneumonia in US adults

OBJECTIVE: We examined the association between serum antioxidant status and mortality from influenza and pneumonia in US adults. DESIGN: Serum concentrations of antioxidants included vitamin C, vitamin A, vitamin E, sum of α- and β-carotene, β-cryptoxanthin, lutein + zeaxanthin and lycopene. We comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Habyeong, Hu, Howard, Park, Sung Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271125/
https://www.ncbi.nlm.nih.gov/pubmed/35000647
http://dx.doi.org/10.1017/S1368980022000027
_version_ 1784744614697107456
author Kang, Habyeong
Hu, Howard
Park, Sung Kyun
author_facet Kang, Habyeong
Hu, Howard
Park, Sung Kyun
author_sort Kang, Habyeong
collection PubMed
description OBJECTIVE: We examined the association between serum antioxidant status and mortality from influenza and pneumonia in US adults. DESIGN: Serum concentrations of antioxidants included vitamin C, vitamin A, vitamin E, sum of α- and β-carotene, β-cryptoxanthin, lutein + zeaxanthin and lycopene. We computed total antioxidant capacity (TAC) as a measure of composite antioxidant status in serum. Survey-weighted Cox proportional hazard models were used to compute hazard ratios (HR) and 95 % CI comparing quartiles of each antioxidant and TAC. SETTING: Data from the US National Health and Nutrition Examination Survey (NHANES)-III. PARTICIPANTS: A total of 7428 NHANES-III participants ≥45 years of age. RESULTS: With a weighted-median follow-up of 16·8 years, 154 participants died from influenza/pneumonia. After adjustment for covariates, serum vitamin C, the sum of α- and β-carotene and TAC were nonlinearly associated with influenza/pneumonia mortality, with the statistically significant smallest HR at the third quartile v. the first quartile (HR = 0·38 (95 % CI: 0·19, 0·77), 0·29 (0·16, 0·51) and 0·30 (0·15, 0·59), respectively). HR comparing the fourth v. the first quartiles were weaker and nonsignificant: 0·57 (95 % CI: 0·27, 1·17), 0·70 (0·41, 1·19) and 0·65 (0·31, 1·35), respectively. Serum lycopene had a monotonic association with influenza/pneumonia mortality (HR = 0·43 (95 % CI: 0·23, 0·83) comparing the fourth v. the first quartile, P (for trend) = 0·01). CONCLUSIONS: The current study suggests that antioxidant intake as reflected by serum concentrations may reduce mortality risk from influenza or pneumonia in the US general population. These findings warrant further confirmation in other populations with different settings (e.g. a shorter-term association with influenza infection).
format Online
Article
Text
id pubmed-9271125
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-92711252023-03-08 Serum antioxidant status and mortality from influenza and pneumonia in US adults Kang, Habyeong Hu, Howard Park, Sung Kyun Public Health Nutr Research Paper OBJECTIVE: We examined the association between serum antioxidant status and mortality from influenza and pneumonia in US adults. DESIGN: Serum concentrations of antioxidants included vitamin C, vitamin A, vitamin E, sum of α- and β-carotene, β-cryptoxanthin, lutein + zeaxanthin and lycopene. We computed total antioxidant capacity (TAC) as a measure of composite antioxidant status in serum. Survey-weighted Cox proportional hazard models were used to compute hazard ratios (HR) and 95 % CI comparing quartiles of each antioxidant and TAC. SETTING: Data from the US National Health and Nutrition Examination Survey (NHANES)-III. PARTICIPANTS: A total of 7428 NHANES-III participants ≥45 years of age. RESULTS: With a weighted-median follow-up of 16·8 years, 154 participants died from influenza/pneumonia. After adjustment for covariates, serum vitamin C, the sum of α- and β-carotene and TAC were nonlinearly associated with influenza/pneumonia mortality, with the statistically significant smallest HR at the third quartile v. the first quartile (HR = 0·38 (95 % CI: 0·19, 0·77), 0·29 (0·16, 0·51) and 0·30 (0·15, 0·59), respectively). HR comparing the fourth v. the first quartiles were weaker and nonsignificant: 0·57 (95 % CI: 0·27, 1·17), 0·70 (0·41, 1·19) and 0·65 (0·31, 1·35), respectively. Serum lycopene had a monotonic association with influenza/pneumonia mortality (HR = 0·43 (95 % CI: 0·23, 0·83) comparing the fourth v. the first quartile, P (for trend) = 0·01). CONCLUSIONS: The current study suggests that antioxidant intake as reflected by serum concentrations may reduce mortality risk from influenza or pneumonia in the US general population. These findings warrant further confirmation in other populations with different settings (e.g. a shorter-term association with influenza infection). Cambridge University Press 2022-12 2022-01-10 /pmc/articles/PMC9271125/ /pubmed/35000647 http://dx.doi.org/10.1017/S1368980022000027 Text en © The Authors 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Kang, Habyeong
Hu, Howard
Park, Sung Kyun
Serum antioxidant status and mortality from influenza and pneumonia in US adults
title Serum antioxidant status and mortality from influenza and pneumonia in US adults
title_full Serum antioxidant status and mortality from influenza and pneumonia in US adults
title_fullStr Serum antioxidant status and mortality from influenza and pneumonia in US adults
title_full_unstemmed Serum antioxidant status and mortality from influenza and pneumonia in US adults
title_short Serum antioxidant status and mortality from influenza and pneumonia in US adults
title_sort serum antioxidant status and mortality from influenza and pneumonia in us adults
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271125/
https://www.ncbi.nlm.nih.gov/pubmed/35000647
http://dx.doi.org/10.1017/S1368980022000027
work_keys_str_mv AT kanghabyeong serumantioxidantstatusandmortalityfrominfluenzaandpneumoniainusadults
AT huhoward serumantioxidantstatusandmortalityfrominfluenzaandpneumoniainusadults
AT parksungkyun serumantioxidantstatusandmortalityfrominfluenzaandpneumoniainusadults